DealsJun 11, 2026, 09:06 AM
Jaguar Health Secures $40M Equity Line of Credit
AI Summary
Jaguar Health, Inc. has entered into a Common Stock Purchase Agreement with an accredited investor, C/M Capital Partners, LP, establishing an Equity Line of Credit (ELOC) for up to $40 million. The agreement allows the company to sell shares of its common stock to the investor under specific terms, including fixed purchases and volume-weighted average price (VWAP) purchases, subject to certain conditions and ownership limitations. The company also agreed to issue $800,000 worth of common stock as Commitment Shares. Stockholder approval for the ELOC has been obtained, enabling potential issuances beyond the initial 19.99% threshold.
Key Highlights
- Jaguar Health entered into a $40 million common stock purchase agreement with an accredited investor.
- The agreement allows for up to $40 million in equity financing through a combination of fixed and VWAP purchases.
- The company will issue $800,000 worth of common stock as Commitment Shares to the investor.
- Purchases are subject to daily volume and dollar amount limitations, and a 4.99% beneficial ownership cap.
- The company obtained stockholder approval for the ELOC, allowing for issuance exceeding 19.99% of outstanding shares.
Price Impact
More from JAGX